Purchase Order 75F40124P00087

Schrodinger LLC has been awarded a firm fixed price purchase order from the Department of Health and Human Services Food and Drug Administration for $288,254.00 to provide a Schrodinger Suite license with maintenance and support. The license will support the FDA's molecular modeling and computational capabilities for drug review and research efforts through June 2028. As a division of Schrodinger, Inc., Schrodinger LLC develops state-of-the-art chemical simulation software for pharmaceutical and biotechnology applications. Schrodinger LLC has received over 20 prior federal contracts from agencies including HHS, FDA, NIH, CDC, Department of the Air Force, and Department of the Navy to provide proprietary small molecule drug discovery software suites without any set aside designations.